Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Sida 1 från 44 resultat
Anti-cancer activity of Androsace umbellata Merr. extract and contained triterpene saponin
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application is a 371 of PCT/KR2006/003668 filed on Sep. 14, 2006, published on Apr. 5, 2007 under publication number WO 2007/037598 A1 which claims priority benefits from South Korean Patent Application Number 10-2005-0091442 filed Sep. 29, 2005, the disclosure of which is hereby incorporated
Polyvalent conjugate vaccine for cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to
Polyvalent conjugate vaccine for cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
Polyvalent conjugate vaccine for cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Tumor-specific antigens have been identified and pursued as targets for vaccines. Previous work from the inventors' has shown that monovalent vaccines utilizing the tumor antigens Globo H, Lewis.sup.y, GM2, glycosylated MUC-1, Tn(c), sTn(c), or TF(c) conjugated to KLH to
Polyvalent conjugate vaccine for cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
Polyvalent conjugate vaccine for cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Throughout this application, various references are referred to. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Tumor-specific
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
1. FIELD OF THE INVENTION
The present invention relates to pharmaceutical compositions that are useful for the prevention and treatment of infectious diseases, primary and metastatic neoplastic diseases (i.e., cancer), neurodegenerative or amyloid diseases, or any other disease wherein the treatment
Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention relates to saponins, and compounds with angeloyl groups isolated from plants, their uses and functions, and methods of their preparations.
SUMMARY OF THE INVENTION
In accordance with these and other objects of the invention, a brief summary of the present
Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Throughout this application, various publications are referenced. Disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
FIELD OF THE INVENTION
This
Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Cancer vaccines are designed to treat cancers by boosting the body's natural ability to protect itself, through the immune system. It has always represented a very attractive therapeutic approach, especially in light of the many shortcomings of conventional surgery,
Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The present invention relates to the field of therapeutic compounds for the treatment of diseases of the skin. In particular the present invention relates to creams made from the herb Tribulus Terrestris which are useful in the treatment of vulvo-vaginitis,
Method of preparing and using compositions extracted from vegetable matter for the treatment of cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, catechins, lignans, phenolic acids, and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa, and
Method of preparing and using isoflavones for the treatment of cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and
Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATION
The present application is the U.S. national stage of International Application PCT/SE2014/050380, filed Mar. 31, 2014, which international application was published on Oct. 9, 2014, as International Publication No, WO2014/163558. The International Application
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is in the field of adjuvants and immunostimulating agents. More particularly, the invention pertains to vaccines and immunostimulating compositions that include saponin-lipophile conjugate adjuvants.
2. Related Art
Saponins
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
